| (USD) | Jan 2024 | Q/Q |
|---|---|---|
| Revenue | 931.6MM | +0% |
| Gross Profit | 623.8MM | +3% |
| Cost Of Revenue | 307.8MM | -4% |
| Operating Income | 153.1MM | +13% |
| Operating Expenses | 470.7MM | - |
| Net Income | 81.2MM | -4% |
| R&D | 39.5MM | +8% |
| G&A | 380.9MM | -2% |
| Amortization | 50.3MM | +8% |
| Interest Expense | 29.9MM | +14% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Today we're going to take a look at the well-established The Cooper Companies, Inc. ( NASDAQ:COO ). The company's stock...
Key Insights Cooper Companies will host its Annual General Meeting on 19th of March Salary of US$1.05m is part of CEO...
SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LH vs. COO: Which Stock Is the Better Value Option?
In this article, we will be taking a look at the 25 most valuable medical device companies in the US. If you are not interested in learning about the emerging trend in medical device industry, head straight to the 5 Most Valuable Medical Device Companies In The US. In the dynamic healthcare technology landscape, the […]
SAN RAMON, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced that its four-for-one stock split will become effective on Friday, February 16, 2024, at 5:00 PM ET, and trading is expected to begin on a stock split-adjusted basis at market open on Tuesday, February 20, 2024, under the existing trading symbol “COO”. The stock split supports Cooper’s desire to make ownership of its stock more accessible to employees and investors. Cooper previously announced on i
In this piece, we will take a look at 11 stocks that might be splitting soon. If you want to skip our overview of what a stock split is and some recent stock market news, then you can take a look at the 5 Stocks That May Be Splitting Soon. When it comes to keeping […]
Cooper Companies (COO) collaborates with Fulgent Genetics to boost newborn genetic screenings. CBR by Cooper Surgical is likely to provide a variety of genetic testing options to its families.
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is concerning.